98
Participants
Start Date
May 14, 2009
Primary Completion Date
June 26, 2012
Study Completion Date
December 5, 2013
eltrombopag olamine
thrombopoietin receptor agonist
Placebo
Placebo tablets with no active pharmaceutical ingredient
GSK Investigational Site, Taipei
GSK Investigational Site, Taipei
GSK Investigational Site, Taichung
GSK Investigational Site, Changhua
GSK Investigational Site, Koebenhavn Oe
GSK Investigational Site, Odense C
GSK Investigational Site, The Bronx
GSK Investigational Site, Berlin
GSK Investigational Site, Marseille
GSK Investigational Site, Caen
GSK Investigational Site, Pittsburgh
GSK Investigational Site, Philadelphia
GSK Investigational Site, Philadelphia
GSK Investigational Site, Baltimore
GSK Investigational Site, Fairfax
GSK Investigational Site, Arlington
GSK Investigational Site, Besançon
GSK Investigational Site, Greenville
GSK Investigational Site, Atlanta
GSK Investigational Site, Toulouse
GSK Investigational Site, Coral Springs
GSK Investigational Site, Lake Worth
GSK Investigational Site, Birmingham
GSK Investigational Site, Vicenza
GSK Investigational Site, Göttingen
GSK Investigational Site, Memphis
GSK Investigational Site, Düsseldorf
GSK Investigational Site, Duisburg
GSK Investigational Site, Detroit
GSK Investigational Site, Florence
GSK Investigational Site, Cologne
GSK Investigational Site, Madison
GSK Investigational Site, Mainz
GSK Investigational Site, St Louis
GSK Investigational Site, Bayonne
GSK Investigational Site, Kansas City
GSK Investigational Site, Stuttgart
GSK Investigational Site, Paris
GSK Investigational Site, Houston
GSK Investigational Site, New Braunfels
GSK Investigational Site, San Antonio
GSK Investigational Site, Munich
GSK Investigational Site, Ulm
GSK Investigational Site, Reggio Calabria
GSK Investigational Site, Santa Monica
GSK Investigational Site, Bobigny
GSK Investigational Site, Stanford
GSK Investigational Site, Boston
GSK Investigational Site, Camden
GSK Investigational Site, Salvador
GSK Investigational Site, Belo Horizonte
GSK Investigational Site, Rio de Janeiro
GSK Investigational Site, Rio de Janeiro
GSK Investigational Site, Dresden
GSK Investigational Site, Hong Kong
GSK Investigational Site, Shatin, New Territories
GSK Investigational Site, San Juan
GSK Investigational Site, Seoul
GSK Investigational Site, Seoul
GSK Investigational Site, Seoul
GSK Investigational Site, Aberdeen
GSK Investigational Site, Glasgow
GSK Investigational Site, Leeds
GSK Investigational Site, London
GSK Investigational Site, London
Lead Sponsor
GlaxoSmithKline
INDUSTRY